Structures by: Joussef A. C.
Total: 49
N-(5,7-Dibromo-8-quinolyl)-3,5-difluorobenzenesulfonamide
C21H10Br2F4N2O4S2
Acta Crystallographica Section E (2006) 62, 7 o2630-o2631
a=9.7580(10)Å b=24.091(2)Å c=9.8510(10)Å
α=90° β=99.560(10)° γ=90°
Aquabis[N-(5,7-dibromoquinolin-8-yl)-4-methylbenzenesulfonamidato- κ^2^N,N]zinc(II)
C32H24Br4N4O5S2Zn
Acta Crystallographica Section E (2006) 62, 6 m1258-m1259
a=15.8969(9)Å b=15.8969Å c=12.1289(9)Å
α=90.00° β=90.00° γ=120.00°
Bis[4-fluoro-N-(quinolin-8-yl)benzenesulfonamidato-κ^2^N,N]zinc(II) hemihydrate
C30H20F2N4O4S2Zn,0.5H2O
Acta Crystallographica Section E (2006) 62, 7 m1719-m1721
a=23.4010(10)Å b=16.8430(10)Å c=17.1860(10)Å
α=90.00° β=123.7100(10)° γ=90.00°
Bis[4-fluoro-N-(quinolin-8-yl)benzenesulfonamidato-κ^2^N,N]copper(II) dichloromethane hemisolvate
C30H20CuF2N4O4S2,0.5CH2Cl2
Acta Crystallographica Section E (2006) 62, 7 m1606-m1608
a=32.228(3)Å b=10.4050(10)Å c=23.817(2)Å
α=90.00° β=130.700(10)° γ=90.00°
6-Nitroquinolin-2(1H)-one
C9H6N2O3
Acta Crystallographica Section E (2005) 61, 9 o2992-o2993
a=11.470(2)Å b=4.8880(6)Å c=15.065(2)Å
α=90.00° β=99.530(10)° γ=90.00°
2,2-Dimethyl-5-[(1,2,4-triazin-3-ylamino)methylene]-1,3-dioxane-4,6-dione
C10H10N4O4
Acta Crystallographica Section E (2005) 61, 9 o2873-o2874
a=6.379(5)Å b=18.239(5)Å c=10.101(5)Å
α=90.00° β=107.331(5)° γ=90.00°
5-{[4-(4-Bromophenyl)thiazol-2-yl]aminomethylene}-2,2-dimethyl-1,3- dioxane-4,6-dione
C16H13BrN2O4S
Acta Crystallographica Section E (2006) 62, 5 o1722-o1723
a=7.8262(6)Å b=9.4869(7)Å c=11.8847(7)Å
α=70.969(5)° β=79.213(6)° γ=77.059(6)°
Bis[N-(2-pyridylmethyl)glycinato]zinc(II) dihydrate
C16H18N4O4Zn,2H2O
Acta Crystallographica Section E (2003) 59, 7 m464-m466
a=9.081(2)Å b=9.480(2)Å c=10.834(2)Å
α=90.00° β=91.99(3)° γ=90.00°
N-Benzyl-8-nitroquinolin-2-amine
C16H13N3O2
Acta Crystallographica Section E (2005) 61, 11 o3837-o3838
a=7.4390(10)Å b=11.2150(10)Å c=16.5410(10)Å
α=90.00° β=93.960(10)° γ=90.00°
N-(5,7-Dibromo-8-quinolyl)-4-fluorobenzenesulfonamide
C15H9Br2FN2O2S
Acta Crystallographica Section E (2005) 61, 11 o3782-o3783
a=18.6360(10)Å b=4.9871(7)Å c=17.9140(10)Å
α=90° β=110.628(7)° γ=90°
4-Nitro-N-(8-quinolyl)benzenesulfonamide
C15H11N3O4S
Acta Crystallographica Section E (2005) 61, 11 o3778-o3779
a=5.0135(6)Å b=20.636(2)Å c=6.9660(10)Å
α=90° β=99.280(10)° γ=90°
2,4,6-Triisopropyl-N-(8-quinolyl)benzenesulfonamide
C24H30N2O2S
Acta Crystallographica Section E (2005) 61, 11 o3780-o3781
a=8.9210(10)Å b=14.303(2)Å c=18.888(3)Å
α=78.000(10)° β=77.770(10)° γ=78.250(10)°
5-[(4-Methoxyphenylamino)methylene]-2,2-dimethyl-1,3-dioxane-4,6-dione
C14H15NO5
Acta Crystallographica Section E (2005) 61, 12 o4121-o4122
a=13.007(3)Å b=7.1317(14)Å c=14.743(3)Å
α=90.00° β=102.14(3)° γ=90.00°
5-[(2-Bromophenylamino)methylene]-2,2-dimethyl-1,3-dioxane-4,6-dione
C13H12BrNO4
Acta Crystallographica Section E (2005) 61, 12 o4252-o4253
a=6.960(5)Å b=9.298(5)Å c=10.424(5)Å
α=95.570(5)° β=101.043(5)° γ=99.508(5)°
4-Fluoro-N-(quinolin-8-yl)benzenesulfonamide
C15H11FN2O2S
Acta Crystallographica Section E (2005) 61, 12 o4387-o4388
a=11.9840(10)Å b=12.4080(10)Å c=9.2792(7)Å
α=90.00° β=102.740(10)° γ=90.00°
2,4,6-Triisopropyl-N-(6-methoxy-2-methyl-8-quinolyl)benzenesulfonamide
C26H34N2O3S
Acta Crystallographica Section E (2006) 62, 2 o420-o422
a=9.1402(8)Å b=11.7266(9)Å c=11.8755(9)Å
α=83.329(6)° β=89.061(7)° γ=78.543(7)°
5-[(6-Fluoro-1,3-benzothiazol-2-ylamino)methylene]-2,2-dimethyl-1,3-dioxane- 4,6-dione
C14H11FN2O4S
Acta Crystallographica Section E (2006) 62, 2 o742-o743
a=6.4330(10)Å b=19.532(2)Å c=11.218(2)Å
α=90° β=102.520(10)° γ=90°
5-[(4-Methylthiazol-2-ylamino)methylene]-2,2-dimethyl-1,3-dioxane-4,6-dione
C11H12N2O4S
Acta Crystallographica Section E (2006) 62, 3 o1163-o1164
a=5.6384(6)Å b=18.562(4)Å c=11.920(2)Å
α=90.00° β=103.140(10)° γ=90.00°
5-(5-Ethyl-1,3,4-thiadiazol-2-ylaminomethylene)-2,2-dimethyl-1,3-dioxane- 4,6-dione
C11H13N3O4S
Acta Crystallographica Section E (2006) 62, 4 o1520-o1521
a=10.733(2)Å b=9.8420(10)Å c=24.650(2)Å
α=90.00° β=90.00° γ=90.00°
Bis[N-(quinolin-8-yl)-2,4,6-triisopropylbenzene-sulfonamidato-κ^2^N,\ N] copper(II)
C48H58CuN4O4S2
Acta Crystallographica Section E (2006) 62, 4 m912-m913
a=24.513(2)Å b=9.4679(7)Å c=19.6000(10)Å
α=90.00° β=102.140(6)° γ=90.00°
Bis[4-n-propyl-N-(8-quinolyl)benzenesulfonamidato-k^2^N,N']zinc(II) dimethylformamide solvate
C36H34N4O4S2Zn,C3H7NO
Acta Crystallographica Section E (2006) 62, 5 m999-m1001
a=15.385(2)Å b=16.928(2)Å c=16.170(2)Å
α=90.00° β=115.300(10)° γ=90.00°
Tetraaqua[3-(1H-imidazol-4-yl)-2-(6-{N-[(1H-imidazol-4-yl)-1-carboxylatoethyl]- carbamoyl}-2-pyridylcarbonylamino)propionato]nickel(II) pentahydrate
C19H25N7NiO10,5H2O
Acta Crystallographica Section E (2001) 57, 6 m224-m226
a=9.610(2)Å b=11.313(2)Å c=13.455(3)Å
α=80.96(3)° β=81.45(3)° γ=77.78(3)°
C9H10N4O4,H2O
C9H10N4O4,H2O
Acta Crystallographica Section E (2005) 61, 8 o2642-o2643
a=18.012(5)Å b=5.356(5)Å c=12.937(5)Å
α=90.00° β=108.786(5)° γ=90.00°
4,5-Dibromo-N-(8-quinolyl)thiophene-2-sulfonamide
C13H8Br2N2O2S2
Acta Crystallographica Section E (2006) 62, 1 o309-o310
a=28.318(2)Å b=7.0471(5)Å c=15.0940(10)Å
α=90.00° β=90.00° γ=90.00°
2,2-Dimethyl-5-[(4-p-tolylthiazol-2-ylamino)methylene]-1,3- dioxane-4,6-dione
C17H16N2O4S
Acta Crystallographica Section E (2006) 62, 8 o3215-o3216
a=7.7951(8)Å b=9.5345(9)Å c=11.8050(10)Å
α=71.034(9)° β=78.564(9)° γ=76.671(9)°
Bis[N-(5,7-dibromoquinolin-8-yl)-3,5-bis(trifluoromethyl)benzenesulfonamidato- κ^2^N,N]zinc(II)
C34H14Br4F12N4O4S2Zn
Acta Crystallographica Section E (2006) 62, 8 m1901-m1903
a=11.7057(6)Å b=12.4768(6)Å c=14.0759(7)Å
α=90.091(4)° β=100.293(4)° γ=100.519(4)°
Aquabis[4-nitro-N-(quinolin-8-yl)benzenesulfonamidato-κ^2^N,N]zinc(II)
C30H22N6O9S2Zn
Acta Crystallographica Section E (2006) 62, 8 m1773-m1775
a=31.407(6)Å b=10.1200(10)Å c=10.3420(10)Å
α=90.00° β=106.94(2)° γ=90.00°
5-[(6-Methylpyridin-2-ylamino)methylene]-2,2-dimethyl-1,3-dioxane-4,6-dione
C13H14N2O4
Acta Crystallographica Section E (2006) 62, 8 o3477-o3478
a=17.1010(10)Å b=7.3540(10)Å c=21.375(2)Å
α=90.00° β=91.868(9)° γ=90.00°
5,7-Dibromo-N-tosylquinolin-8-amine
C16H12Br2N2O2S
Acta Crystallographica Section E (2005) 61, 10 o3435-o3436
a=4.9390(10)Å b=16.595(3)Å c=20.254(4)Å
α=90.00° β=90.00° γ=90.00°
N-(6-Methoxy-2-methyl-8-quinolyl)-4-n-propylbenzenesulfonamide
C20H22N2O3S
Acta Crystallographica Section E (2006) 62, 2 o626-o627
a=8.4437(8)Å b=9.7548(8)Å c=12.1870(8)Å
α=95.254(6)° β=94.757(7)° γ=103.426(8)°
5-(5-Bromothiazol-2-ylaminomethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione ?
C10H9BrN2O4S
Acta Crystallographica Section E (2006) 62, 3 o1062-o1063
a=5.408(5)Å b=18.013(5)Å c=13.114(5)Å
α=90.00° β=100.717(5)° γ=90.00°
2-(1,3-Benzothiazol-2-yl)quinolin-8-ol
C16H10N2OS
Acta Crystallographica Section E (2006) 62, 3 o880-o881
a=12.182(2)Å b=8.0602(8)Å c=26.061(3)Å
α=90.00° β=91.530(10)° γ=90.00°
Bis[2,4,6-triisopropyl-N-(quinolin-8-yl)benzenesulfonamidato-κ^2^N,N]zinc(II)
C48H58N4O4S2Zn
Acta Crystallographica Section E (2006) 62, 3 m516-m517
a=9.9732(6)Å b=14.3281(8)Å c=17.0425(8)Å
α=71.723(5)° β=79.277(4)° γ=69.875(5)°
Bis[4-nitro-N-(quinolin-8-yl)benzenesulfonamidato-κ^2^N,N]copper(II)
C30H20CuN6O8S2
Acta Crystallographica Section E (2006) 62, 3 m518-m519
a=14.101(2)Å b=16.823(2)Å c=13.172(2)Å
α=90.00° β=102.350(10)° γ=90.00°
5-(Aminomethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione
C7H9NO4
Acta Crystallographica Section E (2006) 62, 9 o3866-o3867
a=9.8300(10)Å b=9.6090(10)Å c=16.819(2)Å
α=90.00° β=90.950(10)° γ=90.00°
2-Ethyl-5H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one
C7H7N3OS
Acta Crystallographica Section E (2007) 63, 1 o412-o413
a=32.347(5)Å b=32.347(5)Å c=4.0784(7)Å
α=90.00° β=90.00° γ=120.00°
2-Aminoquinolin-8-yl 4-fluorobenzenesulfonate
C15H11FN2O3S
Acta Crystallographica Section E (2007) 63, 1 o407-o408
a=7.8513(9)Å b=8.0764(9)Å c=11.6800(10)Å
α=89.482(9)° β=79.070(9)° γ=77.738(9)°
2-Aminoquinolin-8-yl 4-p-toluenesulfonate
C16H14N2O3S
Acta Crystallographica Section E (2007) 63, 1 o72-o74
a=8.3340(10)Å b=8.6360(10)Å c=11.8050(10)Å
α=96.350(10)° β=110.230(10)° γ=106.900(10)°
5-(2-Benzoylethenyl)-<i>N</i>-benzyl-2-methoxybenzenesulfonamide
C23H21NO4S
Acta Crystallographica Section E (2007) 63, 7 o3275-o3276
a=10.3671(12)Å b=10.3750(8)Å c=10.7977(14)Å
α=84.880(10)° β=68.790(10)° γ=65.400(10)°
4-n-Propyl-N-(8-quinolyl)benzenesulfonamide
C18H18N2O2S
Acta Crystallographica Section E (2006) 62, 9 o3606-o3607
a=6.7242(8)Å b=14.0310(10)Å c=17.5130(10)Å
α=90.00° β=90.891(9)° γ=90.00°
4-Bromo-N-8-quinolylbenzenesulfonamide
C15H11BrN2O2S
Acta Crystallographica Section E (2007) 63, 4 o1648-o1649
a=6.7800(10)Å b=14.253(3)Å c=15.232(4)Å
α=90.00° β=100.43(2)° γ=90.00°
2-Aminoquinolin-4-yl 2,4,6-triisopropylbenzenesulfonate
C24H30N2O3S
Acta Crystallographica Section E (2006) 62, 12 o5421-o5422
a=9.4310(10)Å b=11.015(2)Å c=12.312(2)Å
α=77.610(10)° β=80.790(10)° γ=69.110(10)°
Aquabis(2-methylquinolin-8-olato-κ^2^N,O)zinc(II)
C20H18N2O3Zn
Acta Crystallographica Section E (2007) 63, 1 m129-m131
a=7.2840(10)Å b=9.131(2)Å c=25.199(5)Å
α=90.00° β=90.00° γ=90.00°
4,5,6,8,9-Pentachloropyrimido[1,2a][1,8]naphthyridin-10-one
C11H2Cl5N3O
Acta Crystallographica Section C (2005) 61, 1 o1-o3
a=16.453(3)Å b=7.1730(10)Å c=22.368(3)Å
α=90.00° β=107.26(2)° γ=90.00°
[(2-(Imidazol-4-yl)ethylamine]{[2-(imidazol-4-yl) ethyl][(1-methylimidazol-2-yl)methyl]amine}copper(II) diperchlorate
C15H24CuN82,2ClO4
Acta Crystallographica Section C (2001) 57, 4 356-358
a=16.785(3)Å b=10.211(2)Å c=14.054(3)Å
α=90° β=102.54(3)° γ=90°
(μ-2,6-Bis{[(2-hydroxyphenyl)(2-pyridylmethyl)amino]methyl}-4-methylphenolato)- bis[diaquanickel(II)] acetate dimetylformamide 0.75-hydrate
C33H37N4Ni2O7,C2H3O2,C3H7NO,0.75H2O
Acta Crystallographica Section C (2000) 56, 10 1188-1190
a=12.170(2)Å b=12.934(3)Å c=14.112(3)Å
α=66.46(3)° β=85.71(3)° γ=79.46(3)°
(3<i>R</i>,8a<i>S</i>)-3-Ethylperhydropyrrolo[1,2-<i>a</i>]pyrazine-1,4-dione
C9H14N2O2
Acta Crystallographica Section E (2010) 66, 2 o417-o418
a=6.8657(4)Å b=9.9258(17)Å c=7.0040(5)Å
α=90.00° β=90.892(6)° γ=90.00°
[(1<i>R</i>*,2<i>S</i>*)-<i>N</i>^1^-Benzyl-2-phenyl-1-(pyridin-2-yl)- <i>N</i>^2^-(pyridin-2-ylmethyl)ethane-1,2-diamine]dichloridozinc(II)
C26H26Cl2N4Zn
Acta Crystallographica Section E (2011) 67, 3 m337-m338
a=9.1716(14)Å b=28.888(2)Å c=10.4304(12)Å
α=90.00° β=109.541(8)° γ=90.00°
Methyl 4-{[6-(4-bromophenyl)-3-oxo-2,3,4,5-tetrahydropyridazin-4-yl]methyl}benzoate
C19H17BrN2O3
Acta Crystallographica Section E (2011) 67, 5 o1230-o1231
a=5.9910(10)Å b=8.9580(10)Å c=17.531(2)Å
α=99.502(11)° β=95.241(12)° γ=105.499(10)°